Notice2022-01886
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 31, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Assessment for the Be Antibiotics Aware Consumer and Healthcare Professional (HCP) Campaign. Individuals who have opted to be contacted for surveys will be screened for eligibility and given access to an online survey to assess the Be Antibiotics Aware campaign, which is designed to optimize antibiotic prescribing and use.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 20 (Monday, January 31, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 20 (Monday, January 31, 2022)]
[Notices]
[Pages 4887-4889]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-01886]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-22CC; Docket No. CDC-2022-0010]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public
[[Page 4888]]
burden and maximize the utility of government information, invites the
general public and other federal agencies the opportunity to comment on
a proposed and/or continuing information collection, as required by the
Paperwork Reduction Act of 1995. This notice invites comment on a
proposed information collection project titled Assessment for the Be
Antibiotics Aware Consumer and Healthcare Professional (HCP) Campaign.
Individuals who have opted to be contacted for surveys will be screened
for eligibility and given access to an online survey to assess the Be
Antibiotics Aware campaign, which is designed to optimize antibiotic
prescribing and use.
DATES: CDC must receive written comments on or before April 1, 2022.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0010 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://Regulations.gov">Regulations.gov</a>. Follow the
instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
<a href="/cdn-cgi/l/email-protection#f09f9d92b0939493de979f86"><span class="__cf_email__" data-cfemail="b1dedcd3f1d2d5d29fd6dec7">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
Assessment for the Be Antibiotics Aware Consumer and HCP Campaign--
New--National Center for Emerging and Zoonotic Infectious Diseases
(NCEZID), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Antibiotic resistance (AR) is one of the most urgent threats to
public health in the United States. Antibiotic resistant bacteria have
grown more virulent, prevalent, and diverse and can spread between
human and animals. Each year there are more than 2.8 million
antibiotic-resistant infections in the United States and 35,000
individuals die as a result. At least 30 percent of antibiotics
prescribed to outpatients and emergency departments are unnecessary
which amounts to 47 million excess prescriptions per year. One of the
main side effects of taking antibiotics is alteration of the microbiome
which could lead to infections such as C. difficile, the inability to
treat infections, prolonged illness, or even death. Risk factors for AR
include lack of knowledge, sub-therapeutic doses, excessive use,
antibiotic residues, and incorrect storage. In addition, there can be
impacts on productivity, healthcare costs, and it can serve as a drain
on the economy.
The National Action Plan calls for federal agencies to accelerate
their response to AR. The goals of the National Action Plan are to
coordinate strategic actions in order to ``improve the health and well-
being of all Americans across the One Health Spectrum.'' In 2015, the
National Action Plan set off with the goal to reduce inappropriate
outpatient antibiotic use by 50 percent by 2020. It prioritizes
prevention and control to prevent infection and reduce the need for
antibiotics. Their approach, One Health, recognizes the inter-
relatedness of humans, animals, and the environment. One way to
decrease the use of unnecessary antibiotic prescriptions is through
antibiotic stewardship.
The goals of the Be Antibiotics Aware campaign are to seek
optimization of antibiotic prescribing and use in order to improve
patient safety and healthcare quality and to combat AR by raising
knowledge and awareness, and motivating behavior change among target
consumer and HCP audiences. Online panel surveys will be utilized to
recruit participants. Surveys will be distributed to consumer target
groups both pre- and post-campaign.
Consumer audiences include:
(1) Spanish speaking women, ages 18-64,
(2) Healthy adults who visit urgent care, ages 18-64,
(3) Community dwelling older adults, ages 65+, and
(4) Family caregivers of nursing home (long-term care) residents.
HCP audiences include:
(1) Hospitalists,
(2) Dentists,
(3) Community pharmacists,
(4) Physicians and advanced practice providers in nursing homes,
and
(5) Nurses in nursing homes.
This evaluation will assist CDC in determining if the Be
Antibiotics Aware media campaign was successful in raising knowledge
and awareness and motivating behavior change among target consumer and
HCP audiences in select markets. The information gathered from this
evaluation will also be used to inform refinement and implementation of
the campaigns (materials and tactics).
CDC requests OMB approval for an estimated 68 annual burden hours.
There is no cost to respondents other than their time.
[[Page 4889]]
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondents Form name respondents responses per response (in (in hours)
respondent hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Consumers...................................... Be Antibiotics Aware Consumer Pilot 50 1 20/60 17
Assessment Pretest.
Consumers...................................... Be Antibiotics Aware Consumer Pilot 50 1 20/60 17
Assessment Posttest.
HCPs........................................... HCP Be Antibiotics Aware Campaign 50 1 20/60 17
Pretest.
HCPs........................................... Be Antibiotics Aware Posttest.......... 50 1 20/60 17
---------------------------------------------------------------
Total...................................... ....................................... .............. .............. .............. 68
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-01886 Filed 1-28-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 31, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.